SEXUAL HEALTH MARKET ANALYSIS

Sexual Health Market, by Product Type (Erectile Dysfunction Drugs, Gender Dysphoria Drugs, Hypoactive Sexual Desire Disorder Drugs, Premature Ejaculation Drugs, and Others), by Gender (Male and Female), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published In : Jan 2020
Code : CMI3364
Pages :167
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Global Sexual Health Market- Regional Analysis

Regional segmentation of the global sexual health market includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, North America is estimated to exhibit significant growth in the sexual health market owing to adoption of inorganic growth strategies by key players to launch drugs in the region. For instance, in the fourth quarter of 2015, Valeant Pharmaceuticals International, Inc. acquired Sprout Pharmaceuticals, Inc. In August 2015, Sprout Pharmaceuticals, Inc. received U.S. FDA approval for its New Drug Application (NDA) for flibanserin. Following the acquisition of Sprout Pharmaceuticals, Inc., Valeant Pharmaceuticals has introduced the flibanserin (Addyi) in the U.S. market.

Geographies covered: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.